
### [MONDO:0003249](http://purl.obolibrary.org/obo/MONDO_0003249)
**Label:** pineal gland cancer

**Subclasses:** [MONDO:0016722](http://purl.obolibrary.org/obo/MONDO_0016722) (pineoblastoma), 

**Corr. equiv. classes:** [Orphanet:251909](http://www.orpha.net/ORDO/Orphanet_251909), 

**Class expressions from DL-Learner:**

- [HP:0030693](http://purl.obolibrary.org/obo/HP_0030693) (Supratentorial neoplasm) 100.00%
- [HP:0030692](http://purl.obolibrary.org/obo/HP_0030692) (Brain neoplasm) 100.00%
- [HP:0010799](http://purl.obolibrary.org/obo/HP_0010799) (Pinealoma) 100.00%
- [HP:0007987](http://purl.obolibrary.org/obo/HP_0007987) (Progressive visual field defects) and [HP:0100012](http://purl.obolibrary.org/obo/HP_0100012) (Neoplasm of the eye) 100.00%
- [HP:0007987](http://purl.obolibrary.org/obo/HP_0007987) (Progressive visual field defects) and [HP:0030693](http://purl.obolibrary.org/obo/HP_0030693) (Supratentorial neoplasm) 100.00%
- [HP:0007987](http://purl.obolibrary.org/obo/HP_0007987) (Progressive visual field defects) and [HP:0030692](http://purl.obolibrary.org/obo/HP_0030692) (Brain neoplasm) 100.00%
- [HP:0007987](http://purl.obolibrary.org/obo/HP_0007987) (Progressive visual field defects) and [HP:0030063](http://purl.obolibrary.org/obo/HP_0030063) (Neuroepithelial neoplasm) 100.00%
- [HP:0007987](http://purl.obolibrary.org/obo/HP_0007987) (Progressive visual field defects) and [HP:0030061](http://purl.obolibrary.org/obo/HP_0030061) (Neuroectodermal neoplasm) 100.00%
- [HP:0007987](http://purl.obolibrary.org/obo/HP_0007987) (Progressive visual field defects) and [HP:0030060](http://purl.obolibrary.org/obo/HP_0030060) (Nervous tissue neoplasm) 100.00%
- [HP:0007987](http://purl.obolibrary.org/obo/HP_0007987) (Progressive visual field defects) and [HP:0012777](http://purl.obolibrary.org/obo/HP_0012777) (Retinal neoplasm) 100.00%
- [HP:0007987](http://purl.obolibrary.org/obo/HP_0007987) (Progressive visual field defects) and [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) 100.00%
- [HP:0007987](http://purl.obolibrary.org/obo/HP_0007987) (Progressive visual field defects) and [HP:0010799](http://purl.obolibrary.org/obo/HP_0010799) (Pinealoma) 100.00%
- [HP:0007987](http://purl.obolibrary.org/obo/HP_0007987) (Progressive visual field defects) and [HP:0009919](http://purl.obolibrary.org/obo/HP_0009919) (Retinoblastoma) 100.00%
- [HP:0007045](http://purl.obolibrary.org/obo/HP_0007045) (Midline brain calcifications) and [HP:0007987](http://purl.obolibrary.org/obo/HP_0007987) (Progressive visual field defects) 100.00%
- [HP:0002898](http://purl.obolibrary.org/obo/HP_0002898) (Embryonal neoplasm) and [HP:0007987](http://purl.obolibrary.org/obo/HP_0007987) (Progressive visual field defects) 100.00%


